secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001193125-25-182695
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed elects AbbVie's Nicole Mowad-Nassar to board; director Sulpizio to retire in Nov 2025
--------------------------------------------------------------------------------

- Nicole Mowad-Nassar elected to ResMed board effective Aug 15, 2025; she is SVP at AbbVie and President of Specialty & U.S. Therapeutics Operations.
- She will serve on the Compensation and Leadership Development Committee; term expires at 2025 annual meeting on Nov 19, 2025.
- Director Richard Sulpizio to retire after 20 years, not standing for reelection at Nov 19 meeting; no disagreement with company.
- Sulpizio previously chaired Compensation, Audit, and Nominating & Governance committees during his tenure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312525182695/0001193125-25-182695-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312525182695/d72598d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-182695

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer